To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02928978
Title Ruxolitinib for Premalignant Breast Disease
Acronym TBCRC042
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Julie Nangia
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Harris Health System - Smith Clinic Houston Texas 77054 United States Details
O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center Houston Texas 77054 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field